The pharmaceutical industry is a global business. The main arena for new drug development is international collaborative clinical trials, application documents for regulatory authorities are prepared in English, and discussions with KOLs (Key Opinion Leaders) and license negotiations are also conducted in English. Global correspondence has become unavoidable, not only for multinational companies but also for Japanese domestic pharmaceutical firms.
However, even if we say "English is necessary in the pharma industry," the "quality" of English required is completely different for R&D (Clinical Development), Medical Affairs (MSL), Regulatory Affairs (RA), Business Development (BD), and management.
In this article, we will map out the overall landscape of English skills required for each major role in the pharmaceutical industry and provide a guide to more detailed articles for each field. Please use this as a guide to understand what is required in your role and to take the first step towards enhancing your English skills most efficiently.
Why English is an "Essential Skill" in the Pharmaceutical Industry
The reason English is indispensable in the pharmaceutical industry stems from the fact that the industry structure itself is global.
First, the mainstream of new drug development is international collaborative clinical trials. The standard development strategy is to conduct clinical trials simultaneously in multiple countries, mainly in Japan, the US, and Europe, and aim for approval in each country with a single clinical data package. The clinical trial protocol, Investigator's Brochure (IB), and Common Technical Document (CTD) for approval applications are all based in English.
Second, international harmonization of regulations is advancing. The guidelines of the ICH (International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use) are all formulated in English, and Japan's PMDA (Pharmaceuticals and Medical Devices Agency) also emphasizes consistency with ICH. Applications and face-to-face consultations with the FDA (U.S. Food and Drug Administration) and EMA (European Medicines Agency) are naturally conducted in English.
Third, in multinational pharmaceutical companies, English is the de facto official internal language. It's common for your boss to be a non-Japanese speaker, internal systems to be in English, and weekly global meetings to be held in English. Even in domestic Japanese firms, English is essential for partnership negotiations with global partners and collaboration with overseas bases, and the number of positions that "do not require English" is decreasing year by year.
And what's important is that the "quality" of English required differs by job function. R&D requires the ability to accurately describe and discuss scientific data in English, while BD requires the ability to negotiate contract terms in English. Even within "business English," the required skill sets in the pharmaceutical industry vary greatly by role. Let's look at this in detail by job function in the following sections.
[Overall Map] A Quick Reference Chart of English Proficiency by Role in the Pharmaceutical Industry
First, let's summarize the overall picture of English proficiency in major roles within the pharmaceutical industry. By understanding where your role is positioned, you can clarify your priorities for English learning.
R&D (Clinical Development): Key English-use scenarios include discussions in global clinical trial team meetings, English reviews of protocols and CSRs (Clinical Study Reports), and dialogue with regulatory authorities in English. The target score is TOEIC 750-900, requiring both scientific writing skills and oral discussion abilities.
Medical Affairs (MA/MSL): Key scenarios include scientific discussions with overseas KOLs, planning and managing advisory boards, engagement at international conferences, and reporting at global MA meetings. The target score is TOEIC 730-900+ / VERSANT 50-65, requiring scientific dialogue and facilitation skills.
Regulatory Affairs (RA): Key scenarios include creating and reviewing the CTD (Common Technical Document) in English, pre-submission consultations with the FDA/EMA (Pre-IND Meeting, Scientific Advice), and handling GxP inspections (audits) in English. The target score is TOEIC 700-860+, with "accuracy" being the most critical feature, as a single word difference can affect approval.
Business Development (BD): Key scenarios include license-in/out negotiations, due diligence (DD), discussions on Term Sheets and Heads of Agreement, and M&A-related communication in English. The target score is TOEIC 800-900+ / IELTS 7.0+, requiring negotiation skills and proficiency in contract English.
Management Level: Key scenarios include global management meetings, Town Hall meetings, leadership during PMI (Post-Merger Integration), and IR (Investor Relations). The target score is TOEIC 900+ / IELTS 7.5+, requiring messaging skills to lead multinational teams.
Physicians (Medical Doctors): Key scenarios include presentations and Q&A sessions at international conferences, writing English-language papers, and conducting medical interviews and obtaining informed consent from non-Japanese speaking patients. The target score varies widely from TOEIC 700-900+ depending on the situation, characterized by the need to switch between academic and clinical English.
What we want to emphasize here is that TOEIC and IELTS scores are merely reference indicators. What is truly required in the pharmaceutical industry is "the ability to actually use English in the frequent situations of one's own job." There are people with a TOEIC score of 900 who freeze during a scientific discussion with a KOL, and there are regulatory affairs specialists with a TOEIC of 750 who confidently handle FDA meetings. Practical ability over scores—this is the reality of English in the pharmaceutical industry.
English for R&D (Clinical Development): The English Skills to Drive Global Clinical Trials
The R&D department of a pharmaceutical company is at the forefront of new drug development and is one of the roles where English is used most routinely.
In international collaborative clinical trials, core documents such as the protocol, Investigator's Brochure (IB), and Clinical Study Report (CSR) are all prepared in English. CRAs (Clinical Research Associates) coordinate with overseas trial sites in English, and project managers discuss development strategies in English at Global Development Team meetings. Medical writers are responsible for writing approval application documents in English.
What is particularly important for English in R&D is "the ability to accurately describe and discuss scientific data in English." Explaining the interpretation of statistical results in English, conducting discussions based on safety data in English, and responding to queries from regulatory authorities in English—these are skills specific to pharmaceutical R&D that go beyond general business English.
Furthermore, interactions with regulatory authorities in English are also crucial. At Pre-IND Meetings with the FDA or during Scientific Advice with the EMA, the ability to explain the validity of the development strategy in English and respond immediately to feedback from the authorities is required.
Essential English for Pharma R&D: Mastering Global Clinical Trials and Scientific Papers
English for Medical Affairs (MA/MSL): "Scientific Dialogue" with KOLs
The Medical Affairs (MA) department, especially MSLs (Medical Science Liaisons), is a role that engages in scientific exchange with KOLs, independent of the sales department.
The English need for MSLs lies not just in information transmission but in "scientific dialogue skills." In one-on-one discussions with overseas KOLs, it requires the ability to ask questions that draw out the KOL's insights while presenting the latest clinical data. English facilitation of advisory boards (AdBo), KOL engagement at international conferences, and reporting insights at global MA meetings—all of these indispensably require the ability to accurately apply scientific expertise in English.
For MSLs, English proficiency is also a career gatekeeper. The reality is that "while you can become an MSL without being fluent in English, you will hit a career ceiling if you can't speak it." The ability to discuss on equal terms with KOLs in English is an essential condition for career advancement to Medical Advisor, Medical Lead, or Global MSL.
English Proficiency for Medical Affairs (MSL): Advanced Scientific Discussions with Global KOLs
English for Regulatory Affairs (RA): Navigating Negotiations and Audits with the FDA/EMA
Regulatory Affairs (RA) is the role within a pharmaceutical company where the "accuracy" of English is most strictly demanded.
The core of RA's English-related work is the creation and review of the CTD (Common Technical Document) in English. The CTD is a common format for approval applications in Japan, the US, and Europe, and the English in Module 2 (Summaries) and Module 5 (Clinical Study Reports) requires a level of precision where the choice of a single word can affect the approval outcome.
In settings like a Pre-IND Meeting with the FDA or Scientific Advice from the EMA, you need the ability to explain the validity of the development plan in English and accurately answer the authorities' questions. Since the design philosophy of Japanese package inserts and US Prescribing Information is fundamentally different, it is also important to be able to explain the differences between the two countries' regulatory frameworks in English.
Furthermore, during GxP inspections (GCP/GMP/GLP audits), the ability to respond immediately in English to questions from FDA or EMA inspectors is required. Since a "slip of the tongue" during an inspection can lead to serious consequences, the skill to respond accurately and concisely in English is a lifeline for RA professionals.
English Skills for Regulatory Affairs (RA) and Inspections: Navigating Negotiations and Audits with the FDA/EMA
English for Business Development (BD): License Negotiations and Due Diligence
Business Development (BD) is a role that negotiates a pharmaceutical company's growth strategy in English.
In license-in/out negotiations, you discuss the license terms for new drug candidates—upfront payments, milestones, royalty rates—in English using a Term Sheet or Heads of Agreement. What's required in this scenario, in addition to understanding scientific data, is the skill of "deal English" to negotiate contract terms.
During due diligence (DD), you scrutinize vast amounts of English documents in a virtual data room (preclinical and clinical data, patent portfolios, regulatory strategy documents, etc.) and assess risks and value through a Q&A process conducted in English.
In M&A (Mergers & Acquisitions) situations, you need the ability to understand the English of documents like the LOI (Letter of Intent) and SPA (Share Purchase Agreement) and lead cross-border communication. M&A in the pharmaceutical industry has been accelerating in recent years, and the importance of English skills for BD is increasing even more.
English for Pharma Business Development (BD) and Licensing Negotiations: A Guide to Successful Out-Licensing and Partnerships
English for Management: "Commanding the Room" in Town Halls, PMI, and IR
For the management of a pharmaceutical company, English is a leadership tool for leading a global organization.
In global management meetings (Board Meetings, Management Committees), you present the strategy for the Japanese market in English and discuss it with executives from other regions. It requires advanced discussion skills not just to report data, but to make strategic proposals and respond to counterarguments.
In Town Hall meetings, you communicate the vision and policies in English to all employees of various nationalities. What is required here is not the kind of discussion had among experts, but "simple and powerful messaging" in English. Clear and memorable English expressions that resonate with a diverse audience, including non-native speakers, are necessary.
During PMI (Post-Merger Integration), leadership communication in English is essential in the process of integrating organizations with different corporate cultures. The ability to present a vision and foster a sense of unity among anxious employees in English is becoming increasingly important with the rise of M&A in the pharmaceutical industry.
In IR (Investor Relations), you explain performance and the development pipeline in English to overseas investors and analysts and respond to their questions. The ability to convey not just financial figures but also the science of new drugs in development in a way that non-experts can understand is required.
English for Pharmaceutical Executives: Leadership Strategies to Command the Room in Town Halls, PMI, and IR
English Skills for Physicians to Succeed in the Pharmaceutical Industry
Physicians hold a unique position within the pharmaceutical industry. This is because English is required in both clinical practice and in academic and industrial activities.
Medical Doctors (MDs) in pharmaceutical companies play a central role in medical judgment within Medical Affairs and development departments. Scientific dialogue with KOLs, medical input into development strategy, and medical discussions with regulatory authorities—all require both high expertise and English proficiency. For career paths to CMO (Chief Medical Officer) or Medical Director in multinational pharmaceutical companies, near-native level English proficiency is a de facto requirement.
A characteristic of a physician's English proficiency is the demand for two different skills: "academic English" and "clinical English." Academic English is necessary for presentations and Q&A at international conferences and for writing English-language papers, requiring the ability to use technical terms accurately. Clinical English is necessary for medical interviews and obtaining informed consent from non-Japanese speaking patients, which conversely requires the ability to rephrase technical terms into plain English that patients can understand.
Medical English for Doctors: From Academic Conferences to Patient Consultations
Three Strategies for Pharmaceutical Professionals to Efficiently Improve Their English Skills
Professionals working in the pharmaceutical industry are busy. Clinical trial timelines, application deadlines, conference seasons—the time available for English study is limited. That's why an efficient and practical learning strategy is crucial.
Strategy 1: Identify the "Frequent Scenarios" in Your Role and Focus on Them
A one-size-fits-all approach to English learning is inefficient. First, identify the situations in your work where English is most needed. For R&D, it might be Global Development Team meetings and protocol reviews; for MSLs, KOL discussions and global MA meetings; for RA, CTD writing and negotiations with authorities. By narrowing down to one or two "most urgent English scenarios for you right now" and concentrating your training there, you can be most efficient.
"I have to use English in an FDA meeting next month," "I have a poster presentation at an international conference in six months," "I will start participating in the global team's weekly meeting next week"—the more specific your goals are, the more focused your learning will be, and the faster you will see results.
Strategy 2: Choose Industry-Specific English Training
General business English conversation lessons cannot cover the context of the pharmaceutical industry (regulatory environment, clinical trial processes, KOL interactions, license negotiations, etc.). The mismatch of "I can speak English, but I can't use it at work" frequently occurs when choosing non-industry-specific training.
Training by instructors who understand the pharmaceutical industry context—for example, role-playing a scientific discussion with someone acting as a KOL, simulations of FDA meetings, or mock license negotiations—brings many times more practical benefits than general English conversation lessons.
Strategy 3: Implement a Practical Cycle of "Practice -> Review -> Improve"
Your English skills won't improve with textbook study alone. It's important to treat your daily English tasks (emails, meetings, presentations) as conscious practice opportunities and to run a cycle of review and improvement.
Specifically, by incorporating habits into your daily routine—such as recording English meetings and listening back to analyze your own speech, stocking expressions used in English emails to create reusable templates, or asking colleagues for feedback after a presentation—your work time naturally transforms into English training time.
Conclusion: Knowing the "English Reality" of Your Role is the First Step
The English required in the pharmaceutical industry varies greatly depending on the job function. The scientific writing skills of R&D, the scientific dialogue skills of MSLs, the accuracy of RA, the negotiation skills of BD, and the leadership messaging of management—each has its own unique "quality of English."
The first step is to identify the situations where English is most needed in your role and focus your training there. This is the most efficient approach for busy pharmaceutical professionals to enhance their English skills.
We will propose the optimal business English plan for you in a free trial lesson. A specialized counselor familiar with the pharmaceutical and life sciences industry will ask about your job function, work content, and current English level to guide you to the most efficient training plan. We offer practical lessons directly linked to your work, whether it's R&D English, MSL English, RA English, BD English, or Management English.
